Condition: DiGeorge Syndrome · 22q11.2 Deletion Syndrome · Sponsor: Albert Einstein College of Medicine
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
This description comes directly from the study's public registry record.
Bernice E. Morrow, PhD · 914-329-4653 · bernice.morrow@einsteinmed.edu
Always discuss trial participation with your own doctor first.
| Albert Einstein College of Medicine | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00556530